INSIGHTS ON LIQUID DOSE MANUFACTURING
-
De-Risking The Transition From Vial To Drug-Device Combination Product
When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.
-
Enhancing Biological Indicators With Enzyme Indicators
Achieve greater process assurance in decontamination cycles. Combining traditional indicators with rapid, quantitative enzyme data reveals performance trends to optimize validation.
-
The Fill/Finish Timeline: What Comes After Manufacturing
The post-manufacturing backend of sterile injectable fill-finish operates in a strict sequence—encompassing inspection, testing, QA review, and complex labeling validation—requiring early planning to avoid timeline delays.
-
Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables
Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
Ready-To-Use Cartridges: Ensuring Compatibility For GLP-1-Based Drugs8/27/2024
Ready-to-use cartridges for GLP-1 applications offer safe, reliable self-administration. See how they can minimize complexities and better align with the stringent demands of modern manufacturing.
-
Developing A Method To Assess Product And Personnel Safety In vH2O2 Decontamination Cycles6/30/2026
Discover how ultra-sensitive spectroscopy transforms decontamination validation, revealing hidden efficiencies that safely cut facility downtime while ensuring absolute safety.
-
Practical USP <1665>/<665> Guide To E&L Risk Assessment2/17/2026
A practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.
-
The Importance Of Tube Welding In Aseptic Bioprocessing3/9/2026
Sensitive biologics rely on aseptic processing and single‑use systems, making dependable sterile connections essential. See how tube welding offers a reliable way to reduce contamination.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
A next‑generation injectable system uses shorter, thinner needles to reduce injection risk, lower force and time requirements, and improve comfort and usability for administering viscous formulations.
-
Pair precise dosing and weight verification with safe automated vial handling, compliant data capture, and easy isolator integration, useful for teams preparing injectable batches.
-
Unused Groninger Aseptic Vial Filling Line, speeds up to 150 vials/minute. Line is designed to CE-norms. Set up for 3 mL, 5 mL with 13mm neck size, 10R, 10Ml, with 20mm neck size, speeds up to 150 vials/minute, 20H, with 20mm neck size, speeds up to 60 vials/minute, and 30mL with 20mm neck size range, speeds up to 50 vials/minute.
-
One (1) used Vectro granulator, mdoel CF360EX, stainless steel construction, 3-5 kg capacity, xp design with controls, 220 volt, serial# CF-110, new 1982.
-
Syringes are complex products that require an extremely precise forming process: Stevanato Group syringe manufacturing lines include several specifications, which are normally optional, such as servomotors for controlling the most critical manufacturing phases (cone forming, total length) and flow meters for automatically regulating the burners.